Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MREO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Mereo Biopharma Group Plc stock price up more than 7.09% on Wednesday
(Updated on May 15, 2024)

Buy candidate since May 15, 2024 PDF

The Mereo Biopharma Group Plc stock price gained 7.09% on the last trading day (Wednesday, 15th May 2024), rising from $2.96 to $3.17. During the last trading day the stock fluctuated 6.34% from a day low at $2.98 to a day high of $3.17. The price has fallen in 6 of the last 10 days but is still up by 0.63% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 13 thousand more shares were traded than the day before. In total, 546 thousand shares were bought and sold for approximately $1.73 million.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $3.23 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -21.21% during the next 3 months and, with a 90% probability hold a price between $1.81 and $2.54 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

MREO Signals & Forecast

Mostly positive signals in the chart today. The Mereo Biopharma Group Plc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $3.07 and $2.99. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 22.87%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Mereo Biopharma Group Plc stock

Mereo Biopharma Group Plc finds support from accumulated volume at $3.15 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.189 between high and low, or 6.34%. For the last week, the stock has had daily average volatility of 6.86%.

Our recommended stop-loss: $2.99 (-5.78%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 20 days ago.)

Trading Expectations (MREO) For The Upcoming Trading Day Of Thursday 16th

For the upcoming trading day on Thursday, 16th we expect Mereo Biopharma Group Plc to open at $3.11, and during the day (based on 14 day Average True Range), to move between $2.97 and $3.37, which gives a possible trading interval of +/-$0.195 (+/-6.15%) up or down from last closing price. If Mereo Biopharma Group Plc takes out the full calculated possible swing range there will be an estimated 12.30% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $3.19 (0.63%) than the support at $3.15 (0.63%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Mereo Biopharma Group Plc stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 2.198 Buy Candidate Upgraded

Predicted Opening Price for Mereo Biopharma Group Plc of Thursday, May 16, 2024

Fair opening price May 16, 2024 Current price
$3.11 ( 1.99%) $3.17

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MREO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.30 3.98 %
R2 3.22 1.70 %
R1 3.18 0.290 %
Current price: 3.17
Support S1 3.03 -4.27 %
S2 2.99 -5.67 %
S3 2.92 -7.95 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.87 22.08 %
R2 3.58 12.93 %
R1 3.19 0.631 %
Current price 3.17
Support S1 3.15 -0.631%
S2 3.10 -2.21%
S3 2.74 -13.56%

FAQ

What is the symbol for Mereo Biopharma Group Plc Stock and on which exchange is it traded?
The symbol for Mereo Biopharma Group Plc is MREO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Mereo Biopharma Group Plc Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

How to buy Mereo Biopharma Group Plc Stock?
Mereo Biopharma Group Plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Mereo Biopharma Group Plc Stock.

What's the current price of Mereo Biopharma Group Plc Stock?
As of the end of day on the May 15, 2024, the price of an Mereo Biopharma Group Plc (MREO) share was $3.17.

What is the 52-week high and low for Mereo Biopharma Group Plc Stock?
The 52-week high for Mereo Biopharma Group Plc Stock is $4.36 and the 52-week low is $0.92.

What is the market capitalization of Mereo Biopharma Group Plc Stock?
As of the May 15, 2024, the market capitalization of Mereo Biopharma Group Plc is 414.574M.

When is the next earnings date for Mereo Biopharma Group Plc?
The upcoming earnings date for Mereo Biopharma Group Plc is Jun 26, 2024.
Click to get the best stock tips daily for free!

About Mereo Biopharma Group Plc

Mereo Biopharma Group Plc Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor. The company is also developing Navicixizumab (OMP-305B83), which has completed Phase ... MREO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT